Pharmacovigilance, By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, Phase 4), By Service (In-House, Contract Outsourcing), By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR ), By End-User (Hospitals, Research Organizations, Industries) and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026


 Request Customization  Sample Request  Ask for Discount
 MDBIW21L67UD  |    Apr 28, 2020


Pharmacovigilance is the process of collection, detection, prevention, and monitoring of the negative effects of pharmaceutical products and drugs. Pharmacovigilance is a process service that works on various drug-related functions including drug discovery its commercialization. Pharmacovigilance also helps to utilize advanced solutions like software. These tools help to reviews, categories of data related to the pharmaceutical and drug products. The increasing drug consumptions, respiratory damages, and the rise in chronic diseases, cancer symptoms increase the demand for Pharmacovigilance. Moreover, a large number of adverse drug reactions also fuels demand. Globally, pharmacovigilance showing significant growth and most of the large pharma, as well as technology companies, are entering the partnership to grab the opportunities in the market. Globally the government also launched centers to support pharmacovigilance services for public safety and security.



The Pharmacovigilance market is projected to reach $xx.x billion by 2025 from $xx.x billion in 2019 at a CAGR of xx.x%. The Pharmacovigilance market report focuses on demand for the Pharmacovigilance products, the number of clinical trials to develop products, a strategic collaboration between biopharma and contract research organizations to support clinical trials. In addition to this, the report also considered R&D spending by pharma and biotech companies to develop innovative products in Pharmacovigilance market. 

The Pharmacovigilance market research report focuses on detailed analysis of market size, forecasting, demand & supply analysis, price trend analysis, market drivers, restraints, opportunities, market trends, and company market share analysis. 

The Pharmacovigilance market is segmented as below

Pharmacovigilance Segments

The segmental analysis is majorly focuses on the impact of drivers and restraints to derive the final value for Pharmacovigilance market.

Segmentation

Clinical Trial Phase

  • Pre-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

Service

  • In-House
  • Contract Outsourcing

Method

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR

End-User

  • Hospitals
  • Research Organizations
  • Industries

The Pharmacovigilance market report also describes the main players including and how they are strengthening their position in the market with the latest innovations, strategic acquisitions, partnership, and collaboration. It also provides the financial analysis, SWOT analysis, company overview and portfolio analysis of the leading players in the Pharmacovigilance market. 

  • F. Hoffmann-La Roche
  • Cognizant
  • Pharmaceutical Clinical Trial Phase Development
  • Bristol-Myers Squibb
  • Covance
  • ICON
  • Accenture
  • Pfizer
  • Clinquest Group
  • Novartis International
  • GlaxoSmithKline
  • PAREXEL International
  • iGATE Corporation
  • iMEDGlobal Corporation
  • inVentiv Health



The Pharmacovigilance market report brings market data at one point to understand the Pharmacovigilance market growth trends, market size, and future scenario of the market. This analysis will help the client to plan their expansion, investment, merger acquisition strategy and bring the improvement. All the data of Pharmacovigilance  market is demonstrated in such a way that the end-user can leverage the analyzed data. The analysis includes all segment and sub-segment analysis and their scope, growth rate, market opportunities and challenges. 

The qualitative analysis of Pharmacovigilance market report includes competitive landscape, key growth, and restraining factors. In addition to this, the PESTEL, Porter's Five, and Value chain analysis enables users to understand how the micro and macro-economic factors have influenced the Pharmacovigilance market. The segmental analysis of Pharmacovigilance market report allows users to understand the competitive factors in the market, which help them to take strategic business decisions for sustainable growth. 

Market Density

Market Density is one-stop market research, advisory, consulting and, industry analysis reports platform. The reports' library providing business data and intelligence information on thousands of micro as well as high growth markets with global as well as regional coverage. Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for B2B, B2C, and government organizations around the globe. Market Density helps global clients to deal with the business challenges in the competitive world for sustainable growth.

Contact information:

4340 Stevens Creek Blvd,
Suite # 172.
San Jose, CA 95129
Ph : +1 669 264 1656
Email : sales@marketdensity.com

 

  • About Us
    • Why Should you buy this report (sample)
    • How this report delivers? (sample)
    • Key Questions Answered(sample)
  • Chapter 1: Introduction to Pharmacovigilance Market
    • Market Definition
    • Market Segmentation
    • Macro Economic Factor Analysis
  • Chapter 2: Executive Summary
  • Chapter 3: Market Factor Analysis
    • Porter’s Five Forces Analysis
    • PESTEL Analysis
    • Value Chain Analysis
    • SWOT Analysis
    • Pricing Analysis
  • Chapter 4: Global Pharmacovigilance Market Estimation & Forecast By Clinical Trial Phase
    • Pre-Clinical
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Chapter 5: Global Pharmacovigilance Market Estimation & Forecast By Service
    • In-House
    • Contract Outsourcing
  • Chapter 6: Global Pharmacovigilance Market Estimation & Forecast By Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Spontaneous Reporting
    • Cohort Event Monitoring
    • EHR
  • Chapter 7: Global Pharmacovigilance Market Estimation & Forecast By End-User
    • Hospitals
    • Research Organizations
    • Industries
  • Chapter 8 Global Pharmacovigilance Market Estimation & Forecast By Region
    • North America
    • Asia Pacific
    • Europe
    • EMEA
    • Latin America
  • Chapter 9 Competitive Landscape
    • Competition Mapping
    • Company Profiles (Suppliers)
      • F. Hoffmann-La Roche
      • Cognizant
      • Pharmaceutical Clinical Trial Phase Development
      • Bristol-Myers Squibb
      • Covance
      • ICON
      • Accenture
      • Pfizer
      • Clinquest Group
      • Novartis International
  • Chapter 10 Recommendations
  • Chapter 11 Acronyms and Assumptions

Purchase options

Single User $ 2100.00
Corporate User $ 3000.00